Knowledge base

Back to Knowledge Base

Unapproved New Drugs

The Food, Drug and Cosmetic Act (“FDCA”) prohibits the sale of unapproved new drugs in interstate commerce: “No person shall introduce or deliver for introduction into interstate commerce any new drug, unless an approval of an application [to the FDA] is effective with respect to such drug. A drug manufacturer or distributor obtains FDA approval by submitting a new drug application (NDA) or abbreviated new drug application (ANDA) in accordance with the FDCA and FDA regulations. Unbeknownst to the public, physicians, and pharmacists; thousands of unapproved drugs have been on the market for decades. Recently, the FDA has announced its intention to take enforcement action against the unapproved rugs, and hundreds of drugs have been taken off the market so far. Unapproved drugs have been sold to federally-funded healthcare programs and are currently the subject of several qui tam lawsuits.

Contact Us

Contact Us

The more detailed the response, the more likely it is that we will be able to evaluate and determine if your potential False Claims Act case falls within our case requirements. If it does, WE WILL RESPOND TO YOU WITHIN 24 HOURS. (Names of potential defendants are not necessary at this point, should you feel more comfortable omitting them.) By law, all communications to us are 100% confidential.

Please enable JavaScript in your browser to complete this form.
No. of Employees at the Company?


Please read the following statement and then click “Send Form”:

Any response to your e-mail will be solely to communicate about our possible representation of you under the qui tam provisions of the False Claims Act. All e-mails submitted to us, whether we take your case or not, are 100% confidential. If we do not respond to your e-mail, then you have communicated information which we cannot address because it appears to fall outside of the False Claims Act or our case requirements.